2019 nCoV/COVID19 RBD protein (Recombinant) {Biotin} (STJP000261) STJP000261 上海玉博生物科技有限公司

2019 nCoV/COVID19 RBD protein (Recombinant) {Biotin} (STJP000261)

如果您对该产品感兴趣的话，可以
产品名称：2019 nCoV/COVID19 RBD protein (Recombinant) {Biotin} (STJP000261)
产品型号：STJP000261
产品展商：ST john's laboratory
产品文档：无相关文档

简单介绍

2019 nCoV/COVID19 RBD protein (Recombinant) {Biotin} (STJP000261)

产品描述

Host:	CHO cells
Note:	STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description:	Recombinant-2019 nCoV/COVID19 RBD-protein was developed from cho cells. For use in research applications.

Conjugation:	Biotin
Formulation:	Lyophilised from 0.2 µm filtered PBS pH 7.4.
Dilution Range:	Spin the vial and reconstite in distilled water to a concentration not less than 0.1 mg/mL. This can then be diluted into other buffers.
Storage Instruction:	The lyophilized protein is stable for at least 1 year from date of receipt at-20°C. NA
Endotoxin:	Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg). NA
Immunoreactivity:	The activity was determined by immobilized human ACE2 Protein binding with biotinylated RBD in a functional ELISA assay, the linear was determined to be 10-100 ng/ml NA

Immunogen Region:	319-514 aa
Immunogen:	DNA sequence encoding the COVID-19 spike RBD protein domain [319-541] accession #6VSB_A including a C-terminal His AVI tag was expressed in CHO Cells. NA

Background

Recombinant 2019-nCoV RBD protein is a protein consisting of 250 amino acid residues, due to glycosylation migrates as an approximately 35kDa protein on SDS-PAGE.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance

产品留言

标题

联系人

联系电话

内容

验证码

点击换一张

注：1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!

温馨提示：为规避购买风险，建议您在购买前务必确认供应商资质与产品质量。
免责申明：以上内容为注册会员自行发布，若信息的真实性、合法性存在争议，平台将会监督协助处理，欢迎举报

产品目录

产品资料

2019 nCoV/COVID19 RBD protein (Recombinant) {Biotin} (STJP000261)